Michael Thurn
Vorstandsvorsitzender bei PHARMAUST LIMITED
Vermögen: 335 184 $ am 31.05.2024
Aktive Positionen von Michael Thurn
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PHARMAUST LIMITED | Direktor/Vorstandsmitglied | 31.05.2024 | - |
Vorstandsvorsitzender | 31.05.2024 | - | |
Marp Therapeutics Pty Ltd.
Marp Therapeutics Pty Ltd. Medical/Nursing ServicesHealth Services Marp Therapeutics Pty Ltd. provides therapy services. The company is based in Melbourne, Australia. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Michael Thurn
Ehemalige bekannte Positionen von Michael Thurn
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PHARMAUST LIMITED | Vorstandsvorsitzender | 01.09.2023 | 23.04.2024 |
BOTANIX PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 12.02.2019 | 26.02.2020 |
Geschäftsführer | 14.02.2017 | 26.02.2020 | |
ERASCA, INC. | Direktor/Vorstandsmitglied | - | - |
Therapeutic Goods Administration | Corporate Officer/Principal | 15.06.2011 | - |
KAZIA THERAPEUTICS LIMITED | Corporate Officer/Principal | - | - |
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Corporate Officer/Principal | - | - |
YM BioSciences Australia Pty Ltd.
YM BioSciences Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., YM BioSciences Australia Pty Ltd. develops cancer treatment pharmaceuticals. The company is based in Melbourne, Australia. | Geschäftsführer | - | - |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Michael Thurn
University of Technology Sydney | Doctorate Degree |
Statistik
International
Australien | 11 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 7 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 3 |
Sektoral
Health Technology | 9 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
KAZIA THERAPEUTICS LIMITED | Health Technology |
BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
PHARMAUST LIMITED | Health Technology |
ERASCA, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Mimetica Pty Ltd.
Mimetica Pty Ltd. Pharmaceuticals: MajorHealth Technology Mimetica Pty Ltd. is a holding company, which engages in the development of products for the treatment of acne. It has a drug discovery platform technology based on the rational design of small molecules that mimic natural peptide hormones. The company was founded in 2001 and is headquartered in Southbank, Australia. | Health Technology |
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Spinifex Pharmaceuticals Pty Ltd. discovers and develops new drugs for the treatment and management of pain. The firm conducts medicinal chemistry and drug discovery activities, preclinical and early-phase clinical studies before seeking a partnership with pharmaceutical company to complete clinical development, file for regulatory approval, and carry out marketing activities. The company was founded in June 2005 and is headquartered in Preston, Australia. | Health Technology |
YM BioSciences Australia Pty Ltd.
YM BioSciences Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., YM BioSciences Australia Pty Ltd. develops cancer treatment pharmaceuticals. The company is based in Melbourne, Australia. | Health Technology |
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
Therapeutic Goods Administration | |
Marp Therapeutics Pty Ltd.
Marp Therapeutics Pty Ltd. Medical/Nursing ServicesHealth Services Marp Therapeutics Pty Ltd. provides therapy services. The company is based in Melbourne, Australia. | Health Services |
- Börse
- Insiders
- Michael Thurn
- Erfahrung